Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Phase 1 Trial
Sort By
Newest First
Sign in
1 / 1
Phase I Trial
Arcus Biosciences Announces Initiation of Phase 1 Trial for AB154, its Anti-TIGIT Antibody
Arcus Biosciences
PR-M08-18-NI-012
Aug 03, 2018
1 / 1
